---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-100434"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:27:54.271593+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Abbott appoints Claire Babineaux-Fontenot to Board; board size expanded to 13

## Summary
- Claire Babineaux-Fontenot named to Abbott's Board of Directors effective September 15, 2022.
- Board size increased from 12 to 13 directors via bylaw amendment on same date.
- By-laws amended and restated to reflect new board size; Exhibit 3.1 filed.

## SEC filing metadata
- accession: 0001104659-22-100434
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465922100434/0001104659-22-100434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465922100434/tm2225651d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-100434
- JSON: https://secwatch.observer/filing/0001104659-22-100434.json
- Plain text: https://secwatch.observer/filing/0001104659-22-100434.txt

## Key facts
- Executive change
  Claire Babineaux-Fontenot was named as Director at ABBOTT LABORATORIES.
  - Action: named
  - Role: Director
  source text: On September 15, 2022, Claire Babineaux-Fontenot was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000110465922100434/0001104659-22-100434-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.